What is the available evidence to support immediate adjuvant intravesical chemotherapy after transurethral resection of superficial transitional cell carcinoma of the bladder?

@article{Schellhammer1998WhatIT,
  title={What is the available evidence to support immediate adjuvant intravesical chemotherapy after transurethral resection of superficial transitional cell carcinoma of the bladder?},
  author={Paul F. Schellhammer},
  journal={Urologic oncology},
  year={1998},
  volume={4 3},
  pages={73-9}
}
The endpoints chosen for analysis of outcome following intravesical therapy can be quite varied. Precise definitions of endpoints are mandatory to permit any comparative assessment between agents or treatment regimens. Although the recurrence endpoint favorably impacts on quality of life by reducing the number of biopsies and resections, the endpoint of greatest importance is progression. Progression of disease is an indication for cystectomy. Unfortunately, the majority of trials testing… CONTINUE READING